Thursday, March 24, 2022

In Conversation: Bill Snider, Partner at BroadOak Capital Partners - BioBuzz

... are the areas of synthetic biology, single cell genomics, and cell and gene therapy which has become more and more important to large pharma.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...